Edna Jann Johnson, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1805 N Jackson St, Tullahoma, TN 37388 Phone: 931-461-1300 Fax: 931-461-1302 |
News Archive
As part of its ongoing commitment to help alleviate the nursing shortage in Maryland and across the United States, The Johnson & Johnson Campaign for Nursing's Future will host the "Promise of Nursing for Maryland" gala on Thursday, September 24 to raise funds to help ease the shortage throughout the region. One hundred percent of the event's proceeds will support regional nursing school grants, faculty fellowships and student scholarships.
A new international study published today [02 September] has shown that treating critically ill patients with COVID-19 with the steroid hydrocortisone improves their chances of recovery.
Management Sciences for Health (MSH), a Massachusetts-based global health nonprofit organization, today announced it is mobilizing its expertise and resources at the epicenter of the Ebola epidemic in Liberia to help the Ministry of Health develop community care centers for Ebola separate from the health facilities; restore essential health services for non-Ebola patients; and, improve the detection and containment of active Ebola cases in Liberian communities.
"White House science adviser John Holdren has replied to questions asked last month by Representative Jim Sensenbrenner (R-Wisc.) about how the Obama Administration has handled the controversy surrounding two studies that showed how to make the H5N1 avian influenza virus transmissible between mammals," ScienceInsider reports.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, is pleased to announce that it has entered into a licensing agreement with AstraZeneca under which AstraZeneca will acquire exclusive global rights to develop, manufacture and commercialise the adenosine A2A receptor antagonist, HTL-1071, a small molecule immuno-oncology candidate, and potential additional A2A receptor-blocking compounds.
› Verified 6 days ago